ロード中...
Cost-effectiveness of bortezomib for multiple myeloma: a systematic review
OBJECTIVES: To review published cost-effectiveness analyses (CEA) assessing bortezomib (BTZ) for multiple myeloma (MM) and explore possible bias affecting the cost-effectiveness of BTZ. METHODS: Literature was searched for published CEAs assessing BTZ or BTZ-containing regimens for MM from 2003 to 2...
保存先:
| 出版年: | Clinicoecon Outcomes Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861606/ https://ncbi.nlm.nih.gov/pubmed/27217786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S104195 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|